Wayne A. Border

20.0k total citations · 7 hit papers
118 papers, 17.0k citations indexed

About

Wayne A. Border is a scholar working on Nephrology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Wayne A. Border has authored 118 papers receiving a total of 17.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Nephrology, 43 papers in Molecular Biology and 23 papers in Immunology and Allergy. Recurrent topics in Wayne A. Border's work include Renal Diseases and Glomerulopathies (36 papers), Chronic Kidney Disease and Diabetes (28 papers) and Cell Adhesion Molecules Research (23 papers). Wayne A. Border is often cited by papers focused on Renal Diseases and Glomerulopathies (36 papers), Chronic Kidney Disease and Diabetes (28 papers) and Cell Adhesion Molecules Research (23 papers). Wayne A. Border collaborates with scholars based in United States, Japan and Germany. Wayne A. Border's co-authors include Nancy A. Noble, Franklin H. Epstein, Erkki Ruoslahti, Erkki Ruoslahti, Seiya Okuda, Diane E. Miller, Lucia R. Languino, Nancy A. Noble, Shoji Kagami and Tatsuo Yamamoto and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Wayne A. Border

118 papers receiving 16.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transforming Growth Factor β in Tissue Fibrosis

1994 2.7k citations Wayne A. Border, Nancy A. Noble et al. profile →
Transforming growth factor-beta in disease: the dark side of tissue repair.

1992 962 citations Wayne A. Border, Erkki Ruoslahti Journal of Clinical Investigation profile →
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

1994 919 citations Shoji Kagami, Wayne A. Border et al. Journal of Clinical Investigation profile →
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1990 867 citations Wayne A. Border, Erkki Ruoslahti et al. profile →
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β

1994 837 citations A. Hildebrand, Wayne A. Border et al. profile →
Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1992 831 citations Wayne A. Border, Yu Yamaguchi et al. profile →
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

1993 727 citations Taku Yamamoto, Takamichi Nakamura et al. profile →

Peers

Wayne A. Border

NEPHR

CCM

SURGE

PRM

Nancy A. Noble United States

David J. Nikolic‐Paterson Australia

Keith A. Hruska United States

Michael Zeisberg Germany

Carla Zoja Italy

Detlef Schlöndorff Germany

Françoise Dignat‐George France

Robert Terkeltaub United States

Moin A. Saleem United Kingdom

Hikaru Sugimoto United States

Nancy A. Noble United States

Wayne A. Border

3.7k ×0.6

2.7k ×0.5

NEPHR

2.0k ×0.8

CCM

1.3k ×0.6

SURGE

1.3k ×0.6

PRM

Citations per year, relative to Wayne A. Border Wayne A. Border (= 1×) peers Nancy A. Noble

Countries citing papers authored by Wayne A. Border

Since Specialization

Citations

This map shows the geographic impact of Wayne A. Border's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne A. Border with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne A. Border more than expected).

Fields of papers citing papers by Wayne A. Border

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne A. Border. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne A. Border. The network helps show where Wayne A. Border may publish in the future.

Co-authorship network of co-authors of Wayne A. Border

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne A. Border. A scholar is included among the top collaborators of Wayne A. Border based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne A. Border. Wayne A. Border is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaedeke, Jens, Nancy A. Noble, & Wayne A. Border. (2005). Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. Kidney International. 68(5). 2042–2049. 58 indexed citations

Huang, Yufeng, Masashi Haraguchi, Daniel A. Lawrence, et al.. (2003). A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. Journal of Clinical Investigation. 112(3). 379–388. 115 indexed citations

Yu, Ling, Wayne A. Border, Yufeng Huang, & Nancy A. Noble. (2003). TGF-β isoforms in renal fibrogenesis. Kidney International. 64(3). 844–856. 151 indexed citations

Haraguchi, Masashi, Wayne A. Border, Yu‐Feng Huang, & Nancy A. Noble. (2001). t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney International. 59(6). 2146–2155. 46 indexed citations

Border, Wayne A. & Nancy A. Noble. (2001). Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases. Seminars in Nephrology. 21(6). 563–572. 33 indexed citations

Peters, Harm, Wayne A. Border, & Nancy A. Noble. (2000). Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney International. 57(3). 992–1001. 32 indexed citations

Yamamoto, Taku, Nancy A. Noble, Diane E. Miller, et al.. (1999). Increased levels of transforming growth factor-β in HIV-associated nephropathy. Kidney International. 55(2). 579–592. 65 indexed citations

Peters, Harm, Wayne A. Border, & Nancy A. Noble. (1999). Targeting TGF- overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis. Nephrology Dialysis Transplantation. 14(suppl 4). 22–23. 10 indexed citations

Peters, Harm, Wayne A. Border, & Nancy A. Noble. (1998). Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney International. 54(5). 1570–1580. 202 indexed citations

10.

Kagami, Shoji, et al.. (1997). Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney International. 51(3). 664–671. 96 indexed citations

11.

Isaka, Yoshitaka, Douglas K. Brees, Kazuko Ikegaya, et al.. (1996). Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Medicine. 2(4). 418–423. 405 indexed citations

12.

Kagami, Shoji, et al.. (1994). Effect of angiotensin II on the expression of plasminogen activator inhibitor -1 in rat mesangial cells. Journal of the American Society of Nephrology. 5(3). 810. 5 indexed citations

13.

Ketteler, Markus, Nancy A. Noble, & Wayne A. Border. (1994). Increased expression of transforming growth factor-?? in renal disease. Current Opinion in Nephrology & Hypertension. 3(4). 446–452. 41 indexed citations

14.

Humes, H. David, et al.. (1993). Role of proteoglycans and cytoskeleton in the effects of TGF-β1 on renal proximal tubule cells. Kidney International. 43(3). 575–584. 46 indexed citations

15.

Ruoslahti, Erkki, Yu Yamaguchi, A. Hildebrand, & Wayne A. Border. (1992). Extracellular Matrix/Growth Factor Interactions. Cold Spring Harbor Symposia on Quantitative Biology. 57(0). 309–315. 51 indexed citations

16.

Border, Wayne A. & Erkki Ruoslahti. (1992). Transforming growth factor-beta in disease: the dark side of tissue repair.. Journal of Clinical Investigation. 90(1). 1–7. 962 indexed citations breakdown →

17.

Groggel, Gerald C., et al.. (1990). Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney International. 37(2). 749–757. 61 indexed citations

18.

Border, Wayne A. & Erkki Ruoslahti. (1990). Transforming growth factor-β1 induces extracellular matrix formation in glomerulonephritis. Cell Differentiation and Development. 32(3). 425–431. 55 indexed citations

19.

Groggel, Gerald C., Peter Hovingh, Wayne A. Border, & Alfred Linker. (1987). Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis.. PubMed. 128(3). 521–7. 37 indexed citations

20.

Glassock, Richard J., et al.. (1981). Glomerulonephritis in Systemic Lupus Erythematosus. American Journal of Nephrology. 1(1). 53–67. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact